Estrogen metabolism and breast cancer: A risk model

Annals of the New York Academy of Sciences

Volumn 1155, Issue , 2009, Pages 68-75

  Parl, Fritz F ^a,b   Dawling, Sheila ^a   Roodi, Nady ^a   Crooke, Philip S ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Estrogen; Genotype; Metabolism; Model; Risk

Indexed keywords

CATECHOL DERIVATIVE; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTRADIOL; ESTRADIOL 3 METHYL ETHER; GLUTATHIONE; GLUTATHIONE TRANSFERASE P1; QUINONE DERIVATIVE;

BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COMPUTER MODEL; COMPUTER SIMULATION; CONFERENCE PAPER; CONJUGATE; CONTROLLED STUDY; ENZYME POLYMORPHISM; ESTROGEN METABOLISM; EXPERIMENTAL MODEL; FEMALE; GAS CHROMATOGRAPHY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IN VITRO STUDY; KINETICS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SCREENING; MASS SPECTROMETRY; METABOLITE; MOLECULAR INTERACTION; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

EID: 61649086428     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03676.x     Document Type: Conference Paper

References (48)

1. MacMahon, B. & M. Feinleib. 1960. Breast cancer in relation to nursing and menopausal history. J. Natl. Cancer Inst. 24 : 733 753.
2. Pike, M.C. et al. 1983. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 303 : 767 770.
3. Gail, M.H. et al. 1989. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst. 81 : 1879 1886.
4. Rockhill, B. et al. 2001. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J. Natl. Cancer Inst. 93 : 358 366.
5. Gaikwad, N.W. et al. 2008. The molecular etiology of breast cancer: Evidence from biomarkers of risk. Int. J. Cancer 122 : 1949 1957.
6. Parl, F.F. 2000. Estrogens, Estrogen Receptor and Breast Cancer. IOS Press. Amsterdam.
7. Yager, J.D. & N.E. Davidson. 2006. Estrogen carcinogenesis in breast cancer. New Engl. J. Med. 354 : 270 282.
8. Yue, W. et al. 2003. Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis. J. Steroid Biochem. Mol. Biol. 86 : 477 486.
9. Cavalieri, E.L. et al. 1997. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94 : 10937 10942.
10. Devanesan, P. et al. 2001. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-α knock-out (ERKO)/Wnt-1 mice: Implications for initiation of mammary tumors. Carcinogenesis 22 : 1573 1576.
11. Fernandez, S.V., I.H. Russo & J. Russo. 2006. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int. J. Cancer 118 : 1862 1868.
12. Li, K.M. et al. 2004. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25 : 289 297.
13. Newbold, R.R. & J.G. Liehr. 2000. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60 : 235 237.
14. Rogan, E.G. et al. 2003. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: Potential biomarkers of susceptibility to cancer. Carcinogenesis 24 : 697 702.
15. Russo, J. et al. 2006. 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 20 : 1622 1634.
16. Russo, J. et al. 2003. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J. Steroid Biochem. Mol. Biol. 87 : 1 25.
17. Saeed, M. et al. 2007. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int. J. Cancer 120 : 1821 1824.
18. Zhao, Z. et al. 2006. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB Rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem. Res. Toxicol. 19 : 475 479.
19. Castagnetta, L.A.M. et al. 2002. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin. Cancer Res. 8 : 3146 3155.
20. Embrechts, J. et al. 2003. Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J. Am. Soc. Mass. Spectrom. 14 : 482 491.
21. Markushin, Y. et al. 2003. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem. Res. Toxicol. 16 : 1107 1117.
22. Belous, A.R. et al. 2007. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res. 67 : 812 817.
23. Crooke, P.S. et al. 2006. Estrogens, enzyme variants, and breast cancer: A risk model. Cancer Epidemiol. Biomarkers Prev. 15 : 1620 1629.
24. Yager, J.D. & J.G. Liehr. 1996. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36 : 203 232.
25. Akanni, A. & Y.J. Abul-Hajj. 1997. Estrogen-nucleic acid adducts: Reaction of 3,4-estrone o-quinone radical anion with deoxyribonucleosides. Chem. Res. Toxicol. 10 : 760 766.
26. Bolton, J.L. et al. 1998. Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11 : 1113 1127.
27. Stack, D.E. et al. 1996. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9 : 851 859.
28. Bolton, J.L. et al. 2000. Role of quinones in toxicology. Chem. Res. Toxicol. 13 : 135 160.
29. Cavalieri, E.L. et al. 2002. Catechol ortho-quinones: The electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23 : 1071 1077.
30. Han, X. & J.G. Liehr. 1995. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: Correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16 : 2571 2574.
31. Liehr, J.G. & D. Roy. 1990. Free radical generation by redox cycling of estrogens. Free Radical Biol. Med. 8 : 415 423.
32. Nutter, L.M. et al. 1994. An o-quinone form of estrogen produces free radicals in human breast cancer cells: Correlation with DNA damage. Chem. Res. Toxicol. 7 : 23 28.
33. Dawling, S. et al. 2001. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: Comparison of wild-type and variant COMT isoforms. Cancer Res. 61 : 6716 6722.
34. Goodman, J.E. et al. 2002. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 12 : 517 528.
35. Hachey, D.L. et al. 2003. Sequential action of phase I and II enzymes cytochrome P450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism. Cancer Res. 63 : 8492 8499.
36. Ali-Osman, F. et al. 1997. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J. Biol. Chem. 15 : 10004 10012.
37. Cascorbi, I., J. Brockmoller & I. Roots. 1996. A C4887A polymorphism in Exon 7 of Human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56 : 4965 4969.
38. Hanna, I.H. et al. 2000. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60 : 3440 3444.
39. Li, D.N. et al. 2000. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics 10 : 343 353.
40. Shimada, T. et al. 2001. Specificity of 17β-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica 31 : 163 176.
41. Dunning, A.M. et al. 1999. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8 : 843 854.
42. Mitrunen, K. & A. Hirvonen. 2003. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in estrogen biosynthesis and metabolism. Mutat. Res. 544 : 9 41.
43. Ritchie, M.D. et al. 2001. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69 : 138 147.
44. Thomas, D.C. 2005. The need for a systematic approach to complex pathways in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14 : 557 559.
45. Dawling, S. et al. 2004. In vitro model of mammary estrogen metabolism: Structural and kinetic differences in mammary metabolism of catechol estrogens 2- and 4-hydroxyestradiol. Chem. Res. Toxicol. 17 : 1258 1264.
46. Bailey, L.R. et al. 1998. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer [Erratum: Cancer Res 1999; 59: 1388]. Cancer Res. 58 : 5038 5041.
47. Bailey, L.R. et al. 1998. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans. Cancer Res. 58 : 65 70.
48. Foster, J.S. et al. 2001. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 12 : 320 327.